TB
TBPH
Theravance Biopharma, Inc. $17.01 1M +0.5% 3M +3.2% YTD -6.3% as of 2026-09-11↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.2%
Next 1 week
-0.3%
Next 1 month
-0.1%
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -0.6% median,
45% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 3
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.45%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 0.52 -0.1% · Seasonal tilt (11y) -0.0%
$6M/day volume
45% volatility
+25% 1-year
-61% from ATH
52-week range · 49% of the way up · -19% from the high
$13.08$21.03
Congressional trades in TBPH Full tracker →
1 member · 0 buys / 1 sells · $15K–$50K disclosed · latest filing Apr 23, 2025.
| SELL | $15K–$50K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.